GI-6207

DB17532InvestigationalOrganism Based Therapies

GI-6207: Overview.

Mechanism: Pharmacologically active on Cell adhesion molecule CEACAM5
Curator reviewed
Code names: GI-6207

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of September 25, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

15Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with GI-6207, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.